1cP-AL-LAD

1cP-AL-LAD is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide. It is thought to act as prodrug of AL-LAD. The drug has been encountered as a novel designer drug.

Use and effects

The dose of 1cP-AL-LAD ranges from 20 to 350μg orally, with an average dose being 100 to 225μg. Its duration is said to be 7 to 10hours. The drug is said to produce psychedelic effects that are weaker and shorter-lasting than those of LSD.

Interactions

Chemistry

Analogues

Related compounds include 1cP-LSD, 1D-LSD, 1P-AL-LAD, and 1T-AL-LAD, among others.

History

1cP-AL-LAD has been sold as a designer drug. It was first identified online in December 2020 and in France in June 2021.

Society and culture

Legal status

Canada

1cP-AL-LAD is not a controlled substance in Canada as of 2025.

United States

1cP-AL-LAD is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.